Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High – Here’s Why

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR)’s share price hit a new 52-week high during trading on Monday . The company traded as high as C$19.59 and last traded at C$19.24, with a volume of 25822 shares trading hands. The stock had previously closed at C$18.80.

Cipher Pharmaceuticals Price Performance

The company has a debt-to-equity ratio of 4.36, a quick ratio of 2.67 and a current ratio of 1.12. The firm has a fifty day simple moving average of C$15.58 and a two-hundred day simple moving average of C$15.07. The firm has a market cap of C$484.64 million, a PE ratio of 18.26 and a beta of 0.73.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.